Pregled bibliografske jedinice broj: 499834
Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections
Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections // Pediatrics, 125 (2010), 50/51; e1171-e1177 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 499834 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections
Autori
Hojsak, Iva ; Abdović, Slaven ; Szajewska, Hania ; Milošević, Milan ; Krznarić, Željko ; Kolaček, Sanja
Izvornik
Pediatrics (0031-4005) 125
(2010), 50/51;
E1171-e1177
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
LGG; nosocomial infections; children
Sažetak
The incidence of nosocomial infections, predominantly gastrointestinal and respiratory, in children in developed countries is high, ranging from 5% to 44%. There is no effective strategy for preventing these infections. The objective of our study was to investigate the role of Lactobacillus GG (LGG) in preventing nosocomial gastrointestinal and respiratory tract infections at a pediatric hospital. We conducted a randomized, double-blind, placebo-controlled trial of 742 hospitalized children. They were randomly allocated to receive for their hospitalization LGG at a dose of 10(9) colony-forming units in 100 mL of a fermented milk product (LGG group, n = 376) or placebo that was the same postpasteurized fermented milk product without LGG (placebo group, n = 366). In the LGG group, compared with the placebo group, we found a significantly reduced risk for gastrointestinal infections (relative risk [RR]: 0.40 [95% confidence interval (CI): 0.25-0.70] ; number needed to treat: 15 [95% CI: 9-34)], respiratory tract infections (RR: 0.38 [95% CI: 0.18-0.85] ; number needed to treat: 30 [95% CI: 16-159]), vomiting episodes (RR: 0.5 [95% CI: 0.3-0.9]), diarrheal episodes (RR: 0.24 [95% CI: 0.10-0.50]), episodes of gastrointestinal infections that lasted >2 days (RR: 0.40 [95% CI: 0.25-0.70]), and episodes of respiratory tract infections that lasted >3 days (RR: 0.4 [95% CI: 0.2-0.9]). Groups did not differ in hospitalization duration (P = .1). LGG administration can be recommended as a valid measure for decreasing the risk for nosocomial gastrointestinal and respiratory tract infections in pediatric facilities.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
072-1083107-2054 - Celijakija u djece: primarna prevencija i patogeneza kromosomske nestabilnosti (Kolaček, Sanja, MZOS ) ( CroRIS)
108-1080316-0300 - Zdravlje na radu i zdravi okoliš (Mustajbegović, Jadranka, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta
Profili:
Željko Krznarić
(autor)
Milan Milošević
(autor)
Slaven Abdović
(autor)
Sanja Kolaček
(autor)
Iva Hojsak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE